The present invention relates to the use of circulating serum Trop-2 as a biomarker that can be used in the clinic as an indicator of tumor burden and to monitor the progression of tumor disease and the efficacy of anti-tumor therapies. The present invention also relates to methods to detect the Trop-2 protein in unfractionated serum.
Use of circulating serum Trop-2 as new tumor biomarker
S. Alberti
Conceptualization
2016-01-01
Abstract
The present invention relates to the use of circulating serum Trop-2 as a biomarker that can be used in the clinic as an indicator of tumor burden and to monitor the progression of tumor disease and the efficacy of anti-tumor therapies. The present invention also relates to methods to detect the Trop-2 protein in unfractionated serum.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
